Wolfgang Hartmann

12.6k total citations
270 papers, 6.8k citations indexed

About

Wolfgang Hartmann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wolfgang Hartmann has authored 270 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 83 papers in Pulmonary and Respiratory Medicine and 57 papers in Oncology. Recurrent topics in Wolfgang Hartmann's work include Sarcoma Diagnosis and Treatment (56 papers), Hedgehog Signaling Pathway Studies (18 papers) and Epigenetics and DNA Methylation (17 papers). Wolfgang Hartmann is often cited by papers focused on Sarcoma Diagnosis and Treatment (56 papers), Hedgehog Signaling Pathway Studies (18 papers) and Epigenetics and DNA Methylation (17 papers). Wolfgang Hartmann collaborates with scholars based in Germany, United States and Switzerland. Wolfgang Hartmann's co-authors include Hans‐Joachim Galla, Eva Wardelmann, Torsten Pietsch, E. Sackmann, Arend Koch, U. Theilen, Sebastian Huss, Reinhard Büttner, Anke Waha and Marcel Trautmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wolfgang Hartmann

242 papers receiving 6.5k citations

Peers

Wolfgang Hartmann
Victor M. Rivera United States
Mark A. Watson United States
Jean A. Laissue Switzerland
Stephan D. Voss United States
Elizabeth Fox United States
Hans E. Grossniklaus United States
Murali Chintagumpala United States
Victor M. Rivera United States
Wolfgang Hartmann
Citations per year, relative to Wolfgang Hartmann Wolfgang Hartmann (= 1×) peers Victor M. Rivera

Countries citing papers authored by Wolfgang Hartmann

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Hartmann more than expected).

Fields of papers citing papers by Wolfgang Hartmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Hartmann. The network helps show where Wolfgang Hartmann may publish in the future.

Co-authorship network of co-authors of Wolfgang Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Hartmann. A scholar is included among the top collaborators of Wolfgang Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Hartmann. Wolfgang Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kailayangiri, Sareetha, et al.. (2024). Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence staining. STAR Protocols. 5(3). 103199–103199. 1 indexed citations
2.
Walter, Carolin, Eric Suero Molina, Walter Stummer, et al.. (2024). Single-cell transcriptomics link gene expression signatures to clinicopathological features of gonadotroph and lactotroph PitNET. Journal of Translational Medicine. 22(1). 1027–1027. 1 indexed citations
3.
Lee, Kwang Seok, Susanne Häfner, Bianca Altvater, et al.. (2024). Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma. Clinical Cancer Research. 30(21). 4974–4986. 1 indexed citations
4.
Wardelmann, Eva, et al.. (2023). Interdependence of SS18-SSX–driven YAP1 and β-Catenin Activation in Synovial Sarcoma. Molecular Cancer Research. 21(6). 535–547. 3 indexed citations
5.
Grünewald, Susanne, Christiane Schaefer, Stefan Zöllner, et al.. (2023). Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas. Bioengineering. 10(4). 464–464. 4 indexed citations
6.
Schweizer, Leonille, Wolfgang Hartmann, Arend Koch, et al.. (2022). Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS‐mutant neurocutaneous melanosis. Neuropathology and Applied Neurobiology. 48(6). e12830–e12830. 6 indexed citations
7.
Trautmann, Marcel, Wolfgang Hartmann, Sarah Sandmann, et al.. (2022). Design of a targeted next‐generation DNA sequencing panel for pediatric T‐cell lymphoblastic lymphoma to unravel biology and optimize treatment. Genes Chromosomes and Cancer. 61(8). 459–470. 1 indexed citations
8.
Krumbholz, Manuela, Andreas Ranft, Jakob Zierk, et al.. (2021). Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma. Clinical Cancer Research. 27(21). 5922–5930. 23 indexed citations
9.
Trautmann, Marcel, Arne Krüger, Inga Grünewald, et al.. (2019). Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma. Molecular Cancer Therapeutics. 18(4). 834–844. 28 indexed citations
10.
Kailayangiri, Sareetha, Bianca Altvater, Claudia Rössig, et al.. (2019). SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma. Clinical Cancer Research. 25(12). 3718–3731. 38 indexed citations
11.
Bäumer, Nicole, Wolfgang Hartmann, Eva Wardelmann, et al.. (2018). Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth. PLoS ONE. 13(7). e0200163–e0200163. 4 indexed citations
12.
Ihle, Michaela A., Sebastian Huss, Wolfgang Hartmann, et al.. (2018). Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLoS ONE. 13(2). e0193048–e0193048. 18 indexed citations
13.
Trautmann, Marcel, Konrad Steinestel, Inga Grünewald, et al.. (2017). FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma. Clinical Cancer Research. 23(20). 6227–6238. 38 indexed citations
14.
Krumbholz, Manuela, Tobias Bäuerle, Abbas Agaimy, et al.. (2016). Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma. Clinical Cancer Research. 22(17). 4356–4365. 61 indexed citations
15.
Waha, Anke, Jörg Felsberg, Wolfgang Hartmann, et al.. (2010). Epigenetic Downregulation of Mitogen-Activated Protein Kinase Phosphatase MKP-2 Relieves Its Growth Suppressive Activity in Glioma Cells. Cancer Research. 70(4). 1689–1699. 67 indexed citations
16.
Hartmann, Wolfgang, Jan Küchler, Arend Koch, et al.. (2009). Activation of Phosphatidylinositol-3′-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival. Clinical Cancer Research. 15(14). 4538–4545. 67 indexed citations
17.
O’Brien, Mary, Aleksandra Szczęsna, Petr Zatloukal, et al.. (2004). Vinorelbine alternating oral and intravenous plus carboplatinin advanced non-small-cell lung cancer: results of a multicentre phase II study. Annals of Oncology. 15(6). 921–927. 17 indexed citations
18.
Lang, D., et al.. (1995). Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress. European Journal of Pediatrics. 154(5). 340–345. 16 indexed citations
19.
Lang, D., et al.. (1995). Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress. European Journal of Pediatrics. 154(5). 340–345. 2 indexed citations
20.
Hartmann, Wolfgang, et al.. (1995). Pollen development in the male sterile plum cultivar Tuleu Gras. 37(1). 2–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026